Hemoglobinopathy is Associated With Total Hip Arthroplasty Indication Even Beyond Sickle Cell Anemia.

Rakutt, Maxwell J; Bracey, Daniel N; Cohen-Rosenblum, Anna; Sculco, Peter K; Sabatini, Franco M; Jacobs, Cale A; Duncan, Stephen T; Landy, David C

Rakutt, Maxwell J; Bracey, Daniel N; Cohen-Rosenblum, Anna; Sculco, Peter K; Sabatini, Franco M; Jacobs, Cale A; Duncan, Stephen T; Landy, David C.

Afiliación

Rakutt MJ; Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY, USA.
Bracey DN; Department of Orthopaedic Surgery, University of North Carolina, Chapel Hill, NC, USA.
Cohen-Rosenblum A; Department of Orthopaedic Surgery, Louisiana State University, New Orleans, LA, USA.
Sculco PK; Complex Joint Reconstruction Center, Hospital for Special Surgery, New York, NY, USA.
Sabatini FM; Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY, USA.
Jacobs CA; Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY, USA.
Duncan ST; Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY, USA.
Landy DC; Department of Orthopaedic Surgery, University of Kentucky, Lexington, KY, USA.

Arthroplast Today ; 19: 101062, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36845292

Palabras clave

Hemoglobinopathy; Osteoarthritis; Osteonecrosis; Sickle cell disease; Total hip arthroplasty

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Arthroplast Today Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google